Mark Sheptoff Financial Planning’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12
Closed -$160 530
2026
Q1
$160 Buy
+12
New +$90 ﹤0.01% 503
2024
Q2
Sell
-61
Closed -$1.15K 440
2024
Q1
$1.15K Buy
61
+10
+20% +$172 ﹤0.01% 372
2023
Q4
$735 Hold
51
﹤0.01% 376
2023
Q3
$885 Hold
51
﹤0.01% 356
2023
Q2
$1.06K Hold
51
﹤0.01% 361
2023
Q1
$1.2K Hold
51
﹤0.01% 359
2022
Q4
$1.42K Buy
51
+47
+1,175% +$1.2K ﹤0.01% 362
2022
Q3
$0 Hold
4
﹤0.01% 392
2022
Q2
$0 Hold
4
﹤0.01% 415
2022
Q1
$0 Hold
4
﹤0.01% 472
2021
Q4
$0 Buy
+4
New +$130 ﹤0.01% 471

Other funds holding OGN

Mark Sheptoff Financial Planning's OGN Position: Q2 2026 in Review

Mark Sheptoff Financial Planning sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 12 shares — an estimated $160 sold.

Mark Sheptoff Financial Planning first reported a position in OGN in Q4 2021 and held it in 11 quarters. The position peaked at $1.42K in Q4 2022. 634 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Mark Sheptoff Financial Planning reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Mark Sheptoff Financial Planning sold 12 Organon & Co shares in Q2 2026, an estimated $160.
  • Mark Sheptoff Financial Planning first reported a position in Organon & Co in Q4 2021 and held it in 11 quarters.
  • Mark Sheptoff Financial Planning's Organon & Co position peaked at $1.42K in Q4 2022.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Mark Sheptoff Financial Planning's 13F filing for Q2 2026, filed 13 Aug 2026.